Stock listing

1GDA Stock Price, News, Filings & Events — Zevra Therapeutics, Inc.

Selected listing: 1GDA · TRADEGATE · EUR · DE

1GDA:TRADEGATE is the public stock listing for Zevra Therapeutics, Inc., a biopharmaceutical company focused on developing innovative therapies for rare diseases. The company is actively engaged in advancing its product pipeline and has been involved in recent clinical trials and regulatory filings. Investors can find updates on the company’s progress, including news releases and upcoming events, which may impact its market presence and stock performance. The page provides essential information for those interested in Zevra Therapeutics' developments in the healthcare sector.

1GDA:TRADEGATEEURDEUpdated July 31, 2026
Zevra Therapeutics, Inc. logo
Ticker
1GDA:TRADEGATE
Asset type
Stock
Market cap
$562.2M
Sector
Health Technology
Industry
Pharmaceuticals: Major
Exchange
TRADEGATE
Currency
EUR

Zevra Therapeutics, Inc. 1GDA:TRADEGATE stock context

1GDA:TRADEGATE is the public stock listing for Zevra Therapeutics, Inc., a biopharmaceutical company focused on developing innovative therapies for rare diseases. The company is actively engaged in advancing its product pipeline and has been involved in recent clinical trials and regulatory filings. Investors can find updates on the company’s progress, including news releases and upcoming events, which may impact its market presence and stock performance. The page provides essential information for those interested in Zevra Therapeutics' developments in the healthcare sector.

Research Zevra Therapeutics, Inc.

Alternate listings